BioMatrix Versus Orsiro Stents for Coronary Artery Disease: A Multicenter, Randomized, Open-Label Study

Comparative studies of ultrathin-strut biodegradable polymer sirolimus-eluting stent (BP-SES) have reported promising results and validated its excellent outcomes in terms of safety and efficacy. However, there are limited studies comparing BP drug-eluting stents with struts of different thicknesses...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Circulation. Cardiovascular interventions 2023-01, Vol.16 (1), p.e012307-e012307
Hauptverfasser:	Yoon, Chang-Hwan, Kwun, Ju-Seung, Choi, Young Jin, Park, Jin Joo, Kang, Si-Hyuck, Kim, Sun-Hwa, Suh, Jung-Won, Youn, Tae-Jin, Kim, Myeong-Kon, Cha, Kwang Soo, Lee, Seung-Hwan, Hong, Bum-Kee, Rha, Seung-Woon, Kang, Woong Chol, Lee, Jae-Hwan, Kim, Sang-Hyun, Chae, In-Ho
Format:	Artikel
Sprache:	eng
Schlagworte:	Absorbable Implants Coronary Artery Disease - diagnostic imaging Coronary Artery Disease - therapy Drug-Eluting Stents Everolimus - adverse effects Humans Percutaneous Coronary Intervention - adverse effects Polymers Prospective Studies Prosthesis Design Sirolimus - adverse effects Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!